Avenue Therapeutics, Inc. (ATXI)
NASDAQ: ATXI · Real-Time Price · USD
2.010
+0.040 (2.03%)
Nov 20, 2024, 4:00 PM EST - Market closed
Avenue Therapeutics Market Cap
Avenue Therapeutics has a market cap or net worth of $2.88 million as of November 21, 2024. Its market cap has decreased by -6.04% in one year.
Market Cap
2.88M
Enterprise Value
-677.98K
1-Year Change
-6.04%
Ranking
Category
Stock Price
$2.01
Market Cap Chart
Since June 27, 2017, Avenue Therapeutics's market cap has decreased from $72.93M to $2.88M, a decrease of -96.06%. That is a compound annual growth rate of -35.38%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Theriva Biologics | 2.82M |
| Lipella Pharmaceuticals | 2.79M |
| iSpecimen | 2.79M |
| Bio-Path Holdings | 2.78M |
| Regional Health Properties | 2.73M |
| ReShape Lifesciences | 2.68M |
| Petros Pharmaceuticals | 2.63M |
| Protagenic Therapeutics | 2.59M |